Korenberg Matthew E

Avg. Two Year Performance

No purchase track record
54% Avg. Sale Return
24% Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return18%29%9%20%0%
Purchase Success Rate1 of 11 of 11 of 11 of 10 of 1
Average Sale Return(5%)31%37%52%54%
Sale Success Rate1 of 21 of 21 of 21 of 22 of 2
Drugs » Drug Manufacturers - Other

PRESIDENT & CHIEF OPERATING:

Holdings: 103.86K shares

Sentiment

Insider Trading Sentiment: Accumulate

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Drugs » Biotechnology

Director:

Holdings: shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--